Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070.
about
Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment.The intricate role of CXCR4 in cancer.Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists.PAX3 and FOXD3 Promote CXCR4 Expression in MelanomaThe Long Noncoding RNA SPRIGHTLY Regulates Cell Proliferation in Primary Human Melanocytes.Emerging targets in cancer management: role of the CXCL12/CXCR4 axis.Perspective of Targeting Cancer-Associated Fibroblasts in Melanoma.Anti-metastatic functions of type 1 interferons: Foundation for the adjuvant therapy of cancer.Exosome secretion promotes chemotaxis of cancer cells.Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell.CXC and CC chemokines as angiogenic modulators in nonhaematological tumors.CXCR4 antagonists suppress small cell lung cancer progression.Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-κB signaling in cervical cancer.Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.Chronic Resveratrol Treatment Inhibits MRC5 Fibroblast SASP-Related Protumoral Effects on Melanoma Cells.The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.[The metastatic niche. Mechanisms and prognostic implications].Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers
P2860
Q30358552-56D0E5EF-B94C-41C0-B261-147B122A60EEQ33677057-AB9C8697-81F2-4E02-B77E-A81F7F8588F6Q35067624-39EB94C6-A8D3-4077-BAAF-DCA36CC4115FQ36016645-B0C4EEFF-2364-44E8-93E0-4E02BE8EE695Q36065213-69A7007A-4A78-484C-83B4-03F3CE8ED76DQ36871135-E0AFB02E-7C71-46B3-959E-12048AFCB6F0Q37225329-838E9233-A7CB-491B-9585-21185A795FD9Q38549236-19E2803E-F954-40EB-9A53-FDDDEB065660Q38715458-32304E37-EEDE-456E-AF35-3AB89DF2A141Q38719158-FF174074-764D-4DAE-BB6B-FBDD6A23E1DBQ38808628-B3EC3474-19B5-4A85-B365-57CAF9E1E878Q40724369-066AA089-AEB0-48E9-A568-F11C97AA6A1FQ42089559-C5650F89-708B-4E97-8B50-69458ACF8EC6Q42704760-B764A13B-4D21-4B09-9986-83D83AE4C165Q47850217-62AEB6BD-C71C-4FB2-94AC-DA60C7B5DC8DQ50782422-CF089894-12CF-47EB-8325-341366979983Q50854225-1CE134FF-0001-40F6-94A8-E4DFA76A4B7CQ53336253-2C47CD45-9A5B-401D-BA82-F4373D676B93Q58694964-3414E21F-019B-4B52-9E1C-9B09E370FF85
P2860
Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070.
@en
Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070.
@nl
type
label
Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070.
@en
Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070.
@nl
prefLabel
Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070.
@en
Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070.
@nl
P2093
P2860
P356
P1476
Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070
@en
P2093
C E Barker
H Marshall
I Swidenbank
J Armstrong
S P Fricker
P2860
P2888
P304
P356
10.1038/BJC.2013.124
P407
P577
2013-03-28T00:00:00Z